tiprankstipranks
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
US Market

Genscript Biotech (GNNSF) Financial Statements

Compare
16 Followers

Genscript Biotech Financial Overview

Genscript Biotech's market cap is currently $3.41B. The company's EPS TTM is $-0.083; its P/E ratio is ―; Genscript Biotech is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 839.53M$ 625.70M$ 490.10M$ 390.85M$ 273.35M
Gross Profit$ 409.55M$ 304.08M$ 282.52M$ 255.89M$ 180.29M
Operating Income$ -415.79M$ -438.11M$ -379.29M$ -204.55M$ -131.35M
EBITDA$ -249.42M$ -389.04M$ -341.57M$ -174.71M$ -112.36M
Net Income$ -95.48M$ -226.85M$ -358.71M$ -204.94M$ -96.91M
Balance Sheet
Cash & Short-Term Investments$ 1.93B$ 1.46B$ 1.41B$ 772.38M$ 426.52M
Total Assets$ 3.39B$ 2.55B$ 2.23B$ 1.45B$ 889.41M
Total Debt$ 416.99M$ 349.80M$ 156.45M$ 55.00M$ 24.13M
Net Debt$ -1.03B$ -674.20M$ -1.02B$ -574.05M$ -228.26M
Total Liabilities$ 1.34B$ 1.18B$ 846.17M$ 631.82M$ 517.11M
Stockholders' Equity$ 1.39B$ 1.01B$ 1.05B$ 901.71M$ 382.80M
Cash Flow
Free Cash Flow$ -444.62M$ -336.40M$ -269.83M$ -272.97M$ -140.33M
Operating Cash Flow$ -286.91M$ -120.29M$ -136.79M$ -151.09M$ -29.95M
Investing Cash Flow$ -357.73M$ -443.30M$ -212.55M$ -100.17M$ -208.63M
Financing Cash Flow$ 1.07B$ 419.32M$ 902.14M$ 624.20M$ -2.78M
Currency in USD

Genscript Biotech Earnings and Revenue History

Genscript Biotech Debt to Assets

Genscript Biotech Cash Flow

Genscript Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis